N,N-Diethyl-2-(2-(4-(2[(18)F]-Fluoroethoxy)Phenyl)5,7Dimethylpyrazolo[1,5A]Pyrimidin-3-Yl)Acetamide

6 trials 3 recruiting

Filter these 6 trials by condition, phase, country and more.

Open in Search →

6 Registered trials

3 Recruiting

3 Completed trials

5 Sponsors

1 Countries

Phase III

Phase II/III

Phase II

Phase I (Other)

Phase III: 1 Phase II/III: 2 Phase II: 2 Phase I (Other): 1

Indications tested

Schizophrenia 1

Sponsors using this IMP

Assistance Publique Hopitaux De Paris 2 Commissariat a l'Energie Atomique et aux Energies Alternatives 1 Groupe Hospitalier Universitaire Paris Psychiatrie Et Neuroscience 1 Hospices Civils De Lyon 1 Institut National De La Sante Et De La Recherche Medicale 1

All trials

6 total

INFLANET - A French Network for PET imaging of neuroinflammation in MS Recruiting

2023-510304-53-00 Phase II/III 1 country Assistance Publique Hopitaux De Paris
Assessment of microglial activation in patients with schizophrenia stratified for C4 complement by PET using [18F]DPA-714 Recruiting

2023-504181-38-00 Phase II/III 1 country Institut National De La Sante Et De La Recherche Medicale
18F-DPA714 PET-MRI study to improve preoperative localisation of the epileptic focus to be resected in drug-resistant partial epilepsy. Recruiting

2024-517638-16-00 Phase I (Other) 1 country Commissariat a l'Energie Atomique et aux Energies Alternatives
Impact of microglial activation on synaptic density in Alzheimer’s disease Ended

2024-516566-11-00 Phase II 1 country Groupe Hospitalier Universitaire Paris Psychiatrie Et Neuroscience
PLAQUE AND BRAIN INFLAMMATION IN SYMPTOMATIC CAROTID STENOSIS: ROLE OF THE FICOLIN-2 STATEMENT Ended

2023-504573-20-00 Phase II 1 country Hospices Civils De Lyon
Impact of post-Acute respiratory distress syndrome COVID sedation on late neuroinflammation (PET-DEXDOCOVID) Ended

2024-511898-30-00 Phase III 1 country Assistance Publique Hopitaux De Paris

Showing 1–6 of 6 trials

← All drugs A–Z